Professor James Mason
Professor of Membrane Biochemistry
Biography
Having completed his undergraduate and D.Phil training at Oxford University, Dr Mason spent six years abroad, in Germany (FMP Berlin and Goethe University in Frankfurt) and then France (ULP, Strasbourg), before returning to the UK and taking up an academic position at King's College London. The research focus of Dr Mason's group is to combine biophysical methods with systems biology approaches (NMR metabolomics coupled with next generation sequencing) to understand how events at biological membranes influence biological outcomes. This is applied to understanding how antibiotics function, how bacteria respond to these and other environmental challenges and the functional consequences of alterations in lung, gut or vaginal microbiomes.
Research
Drug Discovery
The Drug Discovery Group brings together scientific expertise in a broad range of areas, from medicinal chemistry to systems biology and pharmacology.
Antimicrobial Research Theme
Antimicrobial Research Theme
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
The Multiscale Biofilm Research Hub (MBRH)
The Multiscale Biofilm Research Hub (MBRH) has been established to promote interdisciplinary interactions and focus microbial biofilm related research at King’s.
Biofilms at mucosal surfaces
The study of dental caries, periodontitis, vaginal dysbiosis, chronic inflammatory diseases & infections within the oral cavity, intestinal tract & lungs
Project status: Ongoing
Dermatological and non-mucosal biofilms
We are studying the role of biofilms in dermatitis, chronic pain, diabetic ulcers, nail infections and chronic wounds.
Project status: Ongoing
Antimicrobial resistance and biofilm therapeutics
Work involves understanding how biofilms contribute to antimicrobial resistance and the creation of new anti-biofilm therapeutics.
Project status: Ongoing
Microbes in Health & Disease
The Microbes in Health & Diseases Research Interest Group aims to foster collaboration across departments and faculties at KCL to explore the multifaceted role microbes play in health and disease.
News
Six new Studentships for Institute of Pharmaceutical Science
The School of Cancer & Pharmaceutical Science are pleased to announce that there are six new studentships within the Institute of Pharmaceutical Sciences.
Research
Drug Discovery
The Drug Discovery Group brings together scientific expertise in a broad range of areas, from medicinal chemistry to systems biology and pharmacology.
Antimicrobial Research Theme
Antimicrobial Research Theme
Lipids and Membranes Research Interest Group
A Lipids and Membranes Research Interest Group
The Multiscale Biofilm Research Hub (MBRH)
The Multiscale Biofilm Research Hub (MBRH) has been established to promote interdisciplinary interactions and focus microbial biofilm related research at King’s.
Biofilms at mucosal surfaces
The study of dental caries, periodontitis, vaginal dysbiosis, chronic inflammatory diseases & infections within the oral cavity, intestinal tract & lungs
Project status: Ongoing
Dermatological and non-mucosal biofilms
We are studying the role of biofilms in dermatitis, chronic pain, diabetic ulcers, nail infections and chronic wounds.
Project status: Ongoing
Antimicrobial resistance and biofilm therapeutics
Work involves understanding how biofilms contribute to antimicrobial resistance and the creation of new anti-biofilm therapeutics.
Project status: Ongoing
Microbes in Health & Disease
The Microbes in Health & Diseases Research Interest Group aims to foster collaboration across departments and faculties at KCL to explore the multifaceted role microbes play in health and disease.
News
Six new Studentships for Institute of Pharmaceutical Science
The School of Cancer & Pharmaceutical Science are pleased to announce that there are six new studentships within the Institute of Pharmaceutical Sciences.